Exploring the prokaryotic virosphere

Konzepte der bakteriellen Virenabwehr gegen Covid-19

Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome

SARS-CoV-2 Sequence Resources (inkl. Genome Reference Sequence NC_045512)

Genomic characterization of a novel SARS-CoV-2

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Messenger RNA encoding the full-length SARS-CoV-2 spike glycoprotein.

Preprint: A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates

Assessment report: Comirnaty (European Medicines Agency, Committee for Medicinal Products for Human Use)

Synbio Technologies: High-throughput gene synthesis

Ribozyme speed limits (mRNA-Degradation)

An efficient method for long-term room temperature storage of RNA

Cells alter their tRNA abundance to selectively regulate protein synthesis during stress conditions

The SARS-CoV-2 spike protein: balancing stability and infectivity

Neuropilin-1 is a host factor for SARS-CoV-2 infection

ACE2 – das missbrauchte Multitalent

Klinische Tests: Lösliche ACE2-Rezeptoren gegen Covid-19

Role of the early secretory pathway in SARS-CoV-2 infection

Transport from the ER through the Golgi Apparatus

Protein sorting at the ER–Golgi interface

Determinants of translation speed are randomly distributed across transcripts resulting in a universal scaling of protein synthesis times

What is faster, transcription or translation?

Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening

RNA-Stabilität in Eukaryonten

Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life

A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity

The Old, the New, and the Borrowed: SARS-CoV-2 Vaccines and Beyond